Cardio-oncology: an Evolving Hybrid Subspecialty

References

• Mozaffarian D , BenjaminEJ, GoASet al. Heart disease and stroke statistics – 2015 update: a report from the American Heart Association . Circulation131 ( 4 ), e29 – e322 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Howlader N , NooneAM, KrapchoMet al. National Cancer Institute. SEER Cancer Statistics Review, 1975–2010 ( 2013 ). http://seer.cancer.gov/csr/1975_2010/ .
   Google Scholar
• Jemal A , WardEM, JohnsonCJet al. Annual report to the nation on the status of cancer, 1975–2014, featuring survival . J. Natl. Cancer Inst.109 ( 9 ), doi:10.1093/jnci/djx030 ( 2017 ) ( Epub ahead of print ).
   Google Scholar
• Sahni G , ScarabelliTM, EdwardYeh . The diagnosis and management of cardiovascular disease in patients with cancer . In : Hurst’s The Heart (14th Edition) . FusterV, HarringtonRA, NarulaJ, EapenZJ ( Eds ). McGraw-Hill Education, New York, NY, USA ( 2017 ).
   Google Scholar
• Braekkan SK , BorchKH, MathiesenEB, Nj⊘lstadI, WilsgaardT, HansenJB . Body height and risk of venous thromboembolism: the Troms⊘study . Am. J. Epidemiol.171 ( 10 ), 1109 – 1115 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Gussoni G , FrassonS, La ReginaM, Di MiccoP, MonrealM, RIETE Investigators . Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry . Thromb. Res.131 ( 1 ), 24 – 30 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Heit JA , O’FallonWM, PettersonTMet al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study . Arch. Intern. Med.162 ( 11 ), 1245 – 1248 ( 2002 ).
   PubMedGoogle Scholar
• Spencer FA , LessardD, EmeryC, ReedG, GoldbergRJ . Venous thromboembolism in the outpatient setting . Arch. Intern. Med.167 ( 14 ), 1471 – 1475 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• White RH , ZhouH, MurinS, HarveyD . Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996 . Thromb. Haemost.93 ( 2 ), 298 – 305 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Heit JA , SilversteinMD, MohrDNet al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case–control study . Arch. Intern. Med.160 ( 6 ), 809 – 815 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• White RH , ChewHK, ZhouHet al. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults . Arch. Intern. Med.165 ( 15 ), 1782 – 1787 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Khorana AA , FrancisCW, CulakovaEet al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy . J. Thromb. Haemost.5 ( 3 ), 632 – 634 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Pavo N , RadererM, HülsmannMet al. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality . Heart101 ( 23 ), 1874 – 1880 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Siegel RL , MillerKD, JemalA . Cancer statistics 2017 . CA Cancer J. Clin.67 ( 1 ), 7 – 30 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network (NCCN) . www.nccn.org/patients/resources/life_with_cancer/managing_symptoms/cardiac_toxicity.aspx .
   Google Scholar
• National Cancer Institute (NCI) . www.cancer.gov/publications/dictionaries/cancer-terms?CdrID=44004 .
   Google Scholar
• Rahman AM , YusufSW, EwerMS . Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation . Int. J. Nanomedicine2 ( 4 ), 567 – 83 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Ganz WI , SridharKS, FornessTJ . Detection of early anthracycline cardiotoxicity by monitoring the peak filling rate . Am. J. Clin. Oncol.16 ( 2 ), 109 – 112 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Plana JC , GalderisiM, BaracAet al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging . J. Am. Soc. Echocardiogr.27 ( 9 ), 911 – 939 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Billingham ME , MasonJW, BristolMRet al. Anthracycline cardiomyopathy monitored by morphologic changes . Cancer Treat. Rep.62, 865 – 872 ( 1978 ).
   PubMedGoogle Scholar
• Billingham M , BristowMR . Evaluation of anthracycline cardiotoxicity: predictive ability and functional correlation of endomyocardial biopsy . Cancer Treat. Symptoms3, 71 – 76 ( 1984 ).
   Google Scholar
• Yeh ET , BickfordCL . Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis and management . J. Am. Coll. Cardiol.53 ( 24 ), 2231 – 2247 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wouters KA , KremerLC, MillerTL, HermanEH, LipshultzSE . Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies . Br. J. Haematol.131 ( 5 ), 561 – 578 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Hershman DL , ShaoT . Anthracycline cardiotoxicity after breast cancer treatment . Oncology (Williston Park)23 ( 3 ), 227 – 234 ( 2009 ).
   PubMed Web of Science ®Google Scholar